Peritoneal Dialysis-Associated Peritonitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review

被引:0
作者
Tawhari, Ibrahim [1 ,2 ,3 ]
Saggese, Samantha [2 ]
Alshahrani, Shatha S. [1 ]
Asiri, Ghufran [1 ]
Alshahrani, Shatha A. [1 ]
Summan, Sarah [1 ]
Al Qasim, Yousef Y. [1 ]
Al Majbar, Yahya A. [1 ]
机构
[1] King Khalid Univ, Abha, Saudi Arabia
[2] Northwestern Univ Feinberg Sch Med, Chicago, IL USA
[3] King Khalid Univ, Dept Internal Med, Abha 61421, Saudi Arabia
来源
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS | 2024年 / 12卷
关键词
A xylosoxidans; peritonitis; peritoneal dialysis; Achromobacter xylosoxidans infection; tunnel infection; RESISTANCE; PATTERNS;
D O I
10.1177/23247096231220467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Achromobacter xylosoxidans is a gram-negative bacterium that is responsible for rare peritonitis associated with peritoneal dialysis (PD). We present a case of a 64-year-old woman with a medical history of end-stage renal disease undergoing PD who was admitted to the emergency department with abdominal pain and nausea. Physical examination and laboratory studies revealed peritoneal signs and laboratory abnormalities consistent with peritonitis. Intraperitoneal catheter dysfunction was identified and subsequently resolved via laparoscopy. Following a peritoneal fluid culture, A xylosoxidans was identified, leading to the initiation of intraperitoneal meropenem treatment. After an initial improvement, the patient developed an ileus and recurrent abdominal symptoms, and further peritoneal cultures remained positive for A xylosoxidans. Subsequent treatment included intravenous meropenem and vancomycin for Clostridium difficile colitis. Owing to the high likelihood of biofilm formation on the PD catheter by A xylosoxidans, the catheter was removed, and the patient transitioned to hemodialysis. Intravenous meropenem was continued for 2 weeks post-catheter removal. This case highlights the challenges in managing recurrent peritonitis in PD patients caused by multidrug-resistant A xylosoxidans. A high index of suspicion, appropriate microbiological identification, and targeted intraperitoneal and systemic antibiotic treatment, along with catheter management, are crucial in achieving a favorable outcome in such cases.
引用
收藏
页数:5
相关论文
共 25 条
  • [1] Variation in Peritoneal Dialysis-Related Peritonitis Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
    Al Sahlawi, Muthana
    Zhao, Junhui
    McCullough, Keith
    Fuller, Douglas S.
    Boudville, Neil
    Ito, Yasuhiko
    Kanjanabuch, Talerngsak
    Nessim, Sharon J.
    Piraino, Beth M.
    Pisoni, Ronald L.
    Teitelbaum, Isaac
    Woodrow, Graham
    Kawanishi, Hideki
    Johnson, David W.
    Perl, Jeffrey
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (01) : 45 - +
  • [2] Peritoneal dialysis related infections in a tertiary care hospital in Riyadh, Saudi Arabia
    Alfayez, Somia M.
    Alsaqoub, Shahd M.
    Qattan, Abeer Y.
    Alghamdi, Mada A.
    Elfeky, Dalia S.
    Alrowaie, Fadel A.
    Aljasser, Doaa S.
    Syed, Sadiqa B.
    [J]. SAUDI MEDICAL JOURNAL, 2019, 40 (02) : 147 - 151
  • [3] Bilal A., 2014, Crim, V1, DOI [10.5430/crim.v1n2p163, DOI 10.5430/CRIM.V1N2P163]
  • [4] A putative enoyl-CoA hydratase contributes to biofilm formation and the antibiotic tolerance of Achromobacter xylosoxidans
    Cameron, Lydia C.
    Bonis, Benjamin
    Phan, Chi Q.
    Kent, Leslie A.
    Lee, Alysha K.
    Hunter, Ryan C.
    [J]. NPJ BIOFILMS AND MICROBIOMES, 2019, 5 (1)
  • [5] A Rare Cause of Peritoneal Dialysis-Related Peritonitis: Achromobacter denitrificans
    Cankaya, E.
    Keles, M.
    Gulcan, E.
    Uyanik, A.
    Uyanik, H.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2014, 34 (01): : 135 - +
  • [6] Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
    Chalhoub, Hussein
    Kampmeier, Stefanie
    Kahl, Barbara C.
    Van Bambeke, Francoise
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [7] Donderski Rafal, 2018, Case Rep Nephrol, V2018, P9454520, DOI 10.1155/2018/9454520
  • [8] RETRACTED: Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-β1 and Its Signaling Pathway Molecules (Retracted Article)
    Duan, Zhiqiang
    Yao, Jia
    Duan, Nan
    Wang, Min
    Wang, Shiwei
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [9] Genomic Insights into Intrinsic and Acquired Drug Resistance Mechanisms in Achromobacter xylosoxidans
    Hu, Yongfei
    Zhu, Yuying
    Ma, Yanan
    Liu, Fei
    Lu, Na
    Yang, Xi
    Luan, Chunguang
    Yi, Yong
    Zhu, Baoli
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1152 - 1161
  • [10] Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes
    Jakobsen, Tim Holm
    Hansen, Martin Asser
    Jensen, Peter Ostrup
    Hansen, Lars
    Riber, Leise
    Cockburn, April
    Kolpen, Mette
    Hansen, Christine Ronne
    Ridderberg, Winnie
    Eickhardt, Steffen
    Hansen, Marlene
    Kerpedjiev, Peter
    Alhede, Morten
    Qvortrup, Klaus
    Burmolle, Mette
    Moser, Claus
    Kuhl, Michael
    Ciofu, Oana
    Givskov, Michael
    Sorensen, Soren J.
    Hoiby, Niels
    Bjarnsholt, Thomas
    [J]. PLOS ONE, 2013, 8 (07):